Sage Journals: Discover world-class research

Abstract

Introduction

This study examines the α-glucosidase inhibition and antioxidant impact of Moringa oleifera (MO) leaves, which have long been adopted for their medicinal features.

Methods

GC/MS, or gas chromatography/mass spectrometry, was utilized to evaluate the chemical content of MO extracts. The DPPH as well as ABTS assays were utilized to assess antioxidant activity, while the Folin-Ciocalteu reagent was utilized to clarify the total phenolic amount. Its potential for managing diabetes was confirmed by evaluating α-glucosidase inhibition in vitro.

Results

Twenty-five compounds were shared between the 160 compounds in the EtOH extract and the 140 in the EtAc extract. Both Palmitic acid (3.40% in EtAc and 3.57% in EtOH) and α-Linolenic acid (2.95% in EtOH and 2.85% in EtAc) were found at significant levels. The total phenolic amount was 157.14 ± 14.46 mg GAE/g. Antioxidant activity was demonstrated through the DPPH test, which showed an IC50 of 43.01 µg/mL, as well as the ABTS assay, with an IC50 of 21.20 µg/mL. Strong α-glucosidase inhibition was observed with the EtOH-MO extract, resulting in an IC50 of 15.01 µg/mL.

Conclusion

Moringa oleifera extracts demonstrate significant antioxidant and α-glucosidase inhibition activities, attributed to their high phenolic content and beneficial fatty acids. These findings support MO's potential as a natural therapeutic compound for diabetes management as well as prevention.

Keywords

antioxidant properties α-glucosidase inhibition GC-MS

Introduction

Moringa oleifera (MO), often listed as the drumstick tree or the “miracle plant,” is a tropical perennial deciduous plant that originates to the Moringaceae family and has generated a lot of curiosity due to its many health advantages.¹ Understanding the biological properties of both natural and synthetic molecules is essential for recognizing the potential of natural products. By integrating perspectives from other fields, researchers can acquire insights into the relationships between structure and activity, as well as effective therapeutic applications.²

This rapidly increasing crop exhibits a variety of pharmacological impacts, like anti-diabetic, anti-cancer, anti-inflammatory, and antioxidant benefits, as well as containing a range of bioactive chemicals.³ The discovery of new therapeutic targets and intervention strategies will lead to more individualized treatment plans, helping to determine which medications are best for each patient in terms of both risks and benefits.⁴

MO seeds are an essential ingredient of Thai food, and throughout Western Asia, other parts of the plant are valued for their therapeutic qualities, which include regulating blood pressure, controlling thyroid function, improving digestive health, and exhibiting antibacterial effects.^5-7 The plant is useful for food, cosmetic, pharmaceutical, as well as water treatment applications due to its many components, including leaves, pods, seeds, roots, as well as flowers. These parts are affluent in proteins, vitamins C as well as A, omega-3 fatty acids, antioxidants, as well as vital minerals like calcium, potassium, iron, as well as phosphorous.^8,9

MO leaves have been shown to prevent blood glucose and urine glucose levels while improving glucose tolerance in studies involving both healthy as well as diabetic mice. Researchers consider that the fiber in MO leaves contributes to these blood sugar-lowering effects by reducing the rate at which glucose is absorbed in the intestines and postponing the emptying of the stomach.^10-12

In prospective randomized placebo-controlled study, participants with type 2 diabetes mellitus (T2DM) who had not yet received treatment were given either 8 g of MO leaf capsules daily or a placebo for four weeks. There were no discernible differences in refraining plasma glucose (FPG) or HbA1C among the treatment and control groups in this trial, which involved 32 T2DM patients with a mean age of 55 as well as a mean HbA1C of 7.0%. The systolic blood pressure of the MO leaf group was 5 mmHg lower than baseline; however, this difference was not statistically significant. Interestingly, supplementing MO leaves did not cause any negative effects.¹³

MO's potential for environmentally beneficial uses, such as wastewater treatment and nanoparticle manufacturing, has been the subject of recent advancements.¹⁴ Because of their high protein content as well as nutritional value, the plant's leaves are especially noteworthy and can be used to treat malnutrition and as an nutritional supplement for athletes.¹⁵ The many medicinal benefits of MO are attributed to its high levels of phytochemicals, including tannins, phenolics, flavonoids, sterols, saponins, carotenoids, tocopherols, as well as chlorophyll. Its anti-obesity, anti-cancer, anti-diabetic, anti-hypertensive, anti-arthritic, anti-inflammatory, as well as wound-healing qualities make it useful for the development of functional foods, cosmetic products, biodiesel, as well as pharmaceutical applications.¹⁶ This work investigates the antioxidant as well as α-glucosidase inhibitory characteristics of MO leaves, which have long been utilized for their therapeutic benefits.

Materials and Methods

Plant-based Material Collection Along with Extraction

Fresh MO leaves were purchased from the Hafr Al Batin store in the Eastern Province of Saudi Arabia and were allowed to air dry in the shade. Extracts were prepared as described by Kumaran & Joel.¹⁷ Ten grams of the crushed plant samples were taken out in 100 mL of 99% ethanol for 48 h with constant shaking. The extracts were then filtered by Whatman No. 4 paper as well as concentrated under vacuum at 40 °C via a rotary evaporator from Buchi R-215-Switzerland. Furthermore, the ethanol extracts were stored at 4 °C in the dark till further use.

GC-MS Analysis

The extraction method began with 10 g of dried, pulverized plant material, which was extracted separately with 250 mL of Ethanol (EtOH) as well as 250 mL of Ethyl acetate (EtAc). Each extraction took place at room temperature for 24 h with continuous stirring at 250 rpm. The resultant mixes were filtered via Whatman filter paper before being condensed to dryness with a rotary evaporator from Buchi- Germany). For analysis, 10 mg of each dried extract was derivatized using 150 μL of MSTFA (N-Methyl-N-trimethylsilytrifluoroacetamide, containing 1% Trimethyl-chlorosilane) as well as 150 μL of hexane, afterward incubated at 60 °C for 30 min. After filtering via a 0.22 μm syringe filter, then the solutions were transferred to 1.5 mL HPLC vials. GC-MS analysis was performed by injecting 1 μL samples. The analysis was conducted using Lab-Solutions GC-MS software on a Shimadzu with GC-MS-QP 2010 Ultra System (Kyoto, Japan). A Restek Rtx^®-5 ms column, 30.0 m, 0.25 mm, and 0.25 μm, was employed for the separation of metabolites. In addition, Helium (99.9% pure) was employed as the carrier gas at a steady flow rate of 1.0 mL per min. Furthermore, the temperature program ran for 51.43 min, starting at 60 °C, held for three minutes, then ramping up to 140 °C at 7 °C/min, as well as finally reaching 300 °C at 5 °C per min along with a final hold of five min. Moreover, the temperature of the ionization and interface was kept at 250 °C. The full-scan mode was used to detect metabolites within the mass range of 50-650 amu. Additionally, a total volume of 10 μL was injected via a Shimadzu AOC-20i auto-injector in splitless mode. Compounds were identified by matching GC total ion chromatograms (TIC) as well as fragmentation patterns with libraries like NIST/EPA/NIH Mass Spectral Library (NIST 17).^18-21

The Measurement of Total Phenols

The total phenolic content of the extract was measured using the Folin-Ciocalteu reagent, with gallic acid as the standard reference.²² A 0.2 mL aliquot of the 10 mg/mL extract was combined with 1.5 mL of the Folin-Ciocalteu phenol reagent. After allowing the mixture to react for 5 min, 1.5 mL of 6% sodium carbonate was added, and the solution was left to stand at room temperature for 90 min. The absorbance was measured at 725 nm, and the results were expressed as mm of gallic acid equivalent per g of extract (mg GAE/g). All assays were performed in triplicate.

Assessment of Antioxidant Activities

The antioxidant activities of MO extract, dissolved in ethanol, were evaluated based on their ability to scavenge 2,2-diphenyl-1-picrylhydrazyl (DPPH) as well as 3-ethyl-benzothiazoline-6-sulfonic acid (ABTS) radicals. Additionally, both DPPH as well as ABTS assays were conducted as described by Al-Mustafa and Al-Thunibat.²³

DPPH Assay

For the DPPH assay, 50 µL of each extract (final concentration of 10 to 50 µg/mL) was mixed with 950 µL of DPPH solution. After 30 min of incubation in the dark, the absorbance was observed at 517 nm through a Hitachi spectrophotometer. The DPPH radical scavenging properties were calculated via the following formula:

Scavenging ability (%) = (\frac{A_{blank} - A_{sample}}{A_{blank}}) \times 100

where A_blank represents the absorbance of the control component (containing all reagents without the plant extract), and A_sample represents the absorbance of the plant extract. The extract concentrations showing 50% inhibition (IC50) were determined from the plot of inhibition (%) versus extract concentration. All samples were analyzed in triplicate.²⁴

ABTS Assay

For the ABTS assay, an ABTS mixture was prepared by mixing 2.45 mM ABTS in 2.45 mM potassium persulfate in water. The prepared solution was incubated at room temperature for 12 h in the dark. After that, the absorbance of the mixture was adjusted to 0.7 ± 0.02 at 734 nm by diluting it in 5 mM phosphate-buffered saline (PBS) at pH 7.4. Then, 50 µL of each extract (final concentration of 10 to 50 µg/mL) was mixed with 950 µL of the ABTS mixture, followed by 10 min of incubation in the dark. The absorbance was then measured at 734 nm using a spectrophotometer. The radical scavenging impact was calculated using the same formula as for the DPPH assay.²⁵

Measurement of α-glucosidase Inhibition Effectiveness

The α-glucosidase Induction test was performed according to the method described by Indrianingsih et al (2015),²⁶ with some alterations. A 1500 μL solution containing 0.1 M phosphate buffer (pH 7), 5 mM p-nitrophenyl-α-D-glucopyranoside, and 1 U/mL α-glucosidase, with or without varying concentrations of MO ethanolic extract, was continuously measured at 405 nm for 10 min. Acarbose was utilized as the positive control. The percentage inhibition was identified using the following equation:

Inhibition (%) = (\frac{A_{blank} - A_{sample}}{A_{blank}}) \times 100

where A_blank is the average absorbance per minute without the inhibitor and A_sample is the average absorbance per min of the test sample containing the enzyme inhibitor.

Statistical Analysis

The results of this study are presented as means ± standard deviation (SD). Statistical analysis was performed using the Statistical Package for the Social Sciences (SPSS, version 16), and statistical significance was assessed with a P-value of less than .05.

Results

GC-MS Detection of Phytochemicals

GC/MS examination of the extracts’ chemical composition revealed that the EtOH and EtAc extracts had different profiles. The EtOH extract contained 160 compounds, while the EtAc extract had 140, with 25 compounds shared between both extracts. These chemicals were identified by comparing the mass spectrum patterns with those in the Wiley 9 and NIST reference libraries. Table 1 displays the relative abundances of the common compounds as peak area percentages, and Figure 1(a and b) show the chromatographic patterns corresponding to these abundances. Figure 2 illustrates the clarified molecular structures of the main compounds that were identified.

Figure 1.

GC–MS Profile of the Plant Extracts by a- EtOH and b- EtAc.

Figure 2.

Chemical Compounds of the Major Identified Components in EtOH and EtAc Extracts by GC-MS.

Table 1.

GC-MS Assessment of EtOH and EtAc Extracts of MO Extract.

Peak no.	Retention Time (RT)	Name of Compound	Molecular Formula	Molecular Weight (g/mol)	EtOH Extract Area %	EtAc Extract Area %
1.	5.048	Hexamethyldisiloxane	C₆H₁₈OSi₂	162.38	0.01	0.11
2.	11.043	Acetin, bis-1,3-trimethylsilyl ether	C₁₁H₂₆O₄Si₂	278.49	0.05	0.06
3.	11.562	Dodecane	C₁₂H₂₆	170.33	0.01	0.75
4.	12.461	Benzoic Acid, TMS derivative	C₁₀H₁₄O₂Si	194.30	0.04	0.09
5.	13.498	Benzeneacetic acid, TMS derivative	C₁₁H₁₆O₂Si	208.33	0.02	0.05
6.	14.051	2,6,11-trimethyl dodecane	C₁₅H₃₂	212.41	0.01	0.14
7.	15.595	Tetradecane	C₁₄H₃₀	198.39	0.01	1.04
8.	15.821	Pentadecane	C₁₅H₃₂	212.41	0.02	0.06
9.	17.379	Eicosane	C₂₀H₄₂	282.50	0.01	0.16
10.	20.719	Dodecanoic acid, TMS derivative	C₁₅H₃₂O₂Si	272.50	0.04	0.03
11.	24.736	Tetradecanoic acid, TMS derivative	C₁₇H₃₆O₂Si	300.60	0.35	0.75
12.	28.34	3-Octenoic acid, TMS derivative	C₁₁H₂₂O₂Si	214.38	0.37	0.70
13.	28.601	Palmitic Acid	C₁₆H₃₂O₂	256.42	3.57	3.40
14.	29.981	Methyl stearate	C₁₉H₃₈O₂	298.50	0.06	0.09
15.	31.618	α-Linolenic acid	C₁₈H₃₀O₂	278.40	2.95	2.85
16.	32.053	Stearic acid, TMS derivative	C₂₁H₄₄O₂Si	356.70	0.91	0.71
17.	32.191	N,N-Dimethyloctanamide	C₁₀H₂₁NO	171.28	0.14	0.40
18.	34.167	Geranylgeranyl formate	C₂₁H₃₄O₂	318.50	0.11	0.19
19.	36.262	Heneicosane	C₂₁H₄₄	296.60	0.22	1.30
20.	42.045	Tetratetracontane	C₄₄H₉₀	619.20	0.10	0.15
21.	42.611	1-Hexacosanol, TBDMS derivative	C₃₂H₆₈OSi	497.00	0.05	0.14
22.	43.207	ɤ-Tocopherol	C₂₈H₄₈O₂	416.70	0.04	0.12
23.	44.921	Vitamin E	C₂₉H₅₀O₂	430.70	0.03	0.30
24.	45.143	1-Octacosanol, TMS derivative	C₃₁H₆₆OSi	482.90	0.02	0.15
25.	46.144	2,6,10,15,19,23-Hexamethyltetracosa-1,6,10,14,18,22-hexaen-3-ol	C₃₀H₅₀O	426.70	0.02	0.13

Total Phenolic Amount

The Folin-Ciocalteu reagent was employed to quantify the total phenolic components in the EtOH-MO extract, which revealed a total phenolic content of 157.14 ± 14.46 mg GAE/g.

Evaluation of Antioxidant Activity

MO's antioxidant capacity reflects the effectiveness of its oxygen radical-neutralizing components, particularly its phenolic constituents (Figures 3 and 4).

Figure 3.

Antioxidant Activity of EtOH-MO Extracts Determined Based on DPPH % of Inhibition.

Figure 4.

Antioxidant Activity of EtOH-MO Extracts Determined Based on ABTS% of Inhibition.

Assessment of α-Glucosidase Inhibitory Activity

The in vitro inhibition of α-glucosidase was evaluated to confirm the traditional use of MO extract in diabetes treatment. Patients with non-insulin-dependent diabetes mellitus use α-glucosidase inhibitors (Figure 5), which delay carbohydrate digestion as well as absorption, thereby reducing postprandial hyperglycemia.^23,27,28

Figure 5.

In Vitro Effect of EtOH-MO Extract on α-Glucosidase Activity (1 mg/mL at Absorbance 405 nm).

Discussion

This study identified several key chemicals in MO extracts, with Palmitic acid and α-Linolenic acid being the most prevalent. The GC/MS analysis revealed distinct profiles for the EtOH and EtAc extracts (Table 1). Both extracts exhibited high levels of Palmitic acid, a common saturated fatty acid found in various organisms, with concentrations of 3.40% in the EtAc extract and 3.57% in the EtOH extract. Additionally, α-Linolenic acid was significantly present at 2.95% in the EtOH extract and 2.85% in the EtAc extract, contributing 6.97% and 5.80% of the total extracts, respectively. Another important compound identified was N,N-Dimethyloctanamide, with concentrations of 0.14% in the EtOH extract and 0.40% in the EtAc extract. Notably, N,N-dimethyloctanamide may interact with the enzyme's active site, potentially inhibiting its activity and slowing the conversion of disaccharides to glucose.

These findings highlight the potential health benefits of MO extracts and underscore the importance of further investigation into their biochemical properties and therapeutic applications. The biological implications of these findings are significant, particularly concerning α-Linolenic acid. Prior studies indicate that α-Linolenic acid, along with other unsaturated fatty acids like Palmitoleate, protects renal proximal tubular cells from cell death and endoplasmic reticulum (ER) stress induced by Palmitic acid. This protective mechanism involves the reduction of critical ER stress markers, including phosphorylated eIF2α, CHOP, and GRP78. Furthermore, these protective effects extend to other ER stress inducers, such as salubrinal and tunicamycin, suggesting that unsaturated fatty acids play a vital role in maintaining cellular homeostasis by blocking ER stress pathways and preventing apoptotic cell death.^27,29-34

The total phenolic content in the EtOH-MO extract was quantified using the Folin-Ciocalteu reagent, yielding a measurement of 157.14 ± 14.46 mg GAE/g. This finding highlights the significant concentration of phenolic compounds, which are well known for their antioxidant properties and potential health benefits. The improved extraction efficiency of the EtOH extract can be attributed to the use of a water-ethanol mixture,²⁰ which enhances both polarity and the solubility of the phenolic compounds. This combination allows for better solubilization, resulting in a more effective extraction process. Supporting our results, Dehshahri et al²⁸ reported a phenolic content of 88.05 ± 1.08 mg/g in the methanolic leaf extract of Moringa peregrina, underscoring the vital role of phenols from medicinal herbs as significant antioxidants and free radical terminators. Furthermore, The average phenolic content in the ethanolic extracts of MO seeds was 11.85 mg GAE/g,³⁵ while the flowers contained 19.31 mg/g of gallic acid equivalent total phenolics in dry extract, although these extracts exhibited only moderate antioxidant activity.³⁶

The antioxidant properties of these phenolic compounds, due to their redox capabilities, enable them to act as reducing agents and singlet oxygen inhibitors.³⁷ The DPPH method is a reliable technique for evaluating the antioxidant properties of plant extracts.³⁸ Our findings confirmed that MO exhibited potent antioxidant activity, as demonstrated by the DPPH percentage inhibition and IC50 measurements. The antioxidant capacity of the extract was assessed at 25.33 µg/mL, yielding an IC50 value of 43.01 µg/mL. Additionally, the EtOH extract of MO exhibited substantial antioxidant capacity, as indicated by the ABTS percentage inhibition values and IC50 levels, shown in Figure 4. Further antioxidant analysis demonstrated strong capabilities through two assays. The ABTS test revealed an antioxidant ability of 41.80 μg/mL, with an IC50 value of 21.20 μg/mL, while the DPPH assay yielded an IC50 of 70.05 μg/mL. Although both extracts had higher IC50 values compared to BHT, a widely used synthetic phenolic antioxidant, this finding suggests that the extracts may provide a safer alternative, minimizing the risks associated with enzymatic or lipid modifications, as well as potential carcinogenic and mutagenic effects.³⁹

MO is acclaimed for its antioxidant properties, with its leaves, seeds, pods, and flowers containing various bioactive compounds that enhance its efficacy. Rich in flavonoids, phenolic acids, and tannins, MO acts as a potent free radical scavenger. Compounds like quercetin and kaempferol are particularly effective in neutralizing reactive oxygen species (ROS). Additionally, high concentrations of vitamins C and E further bolster antioxidant activity by preventing lipid peroxidation and protecting cellular structures from oxidative stress. Bioactive compounds in MO, including Tetratetracontane, promote the production of endogenous antioxidants like glutathione and catalase, thereby reducing oxidative damage to DNA, proteins, and lipids. In vitro studies have shown that MO leaf extracts exhibit significant DPPH radical scavenging effects.^6,37-41 In vivo studies involving animal models treated with MO leaf extract reported reduced levels of oxidative markers, such as malondialdehyde (MDA), alongside increased activity of antioxidant enzymes.^42,43 Furthermore, supplementation with MO powder or extracts has been linked to reduced oxidative stress markers and improved antioxidant status in individuals experiencing oxidative stress due to chronic conditions or environmental factors.⁴⁴

The EtOH-MO extract displayed the highest α-glucosidase inhibition (IC50 = 15.01 µg/mL), demonstrating a clear, concentration-dependent effect on α-glucosidase activity, as depicted in Figure 5. Previous investigations have highlighted the hypoglycemic effects of compounds like β-sitosterol and stigmasterol found in Dillenia indica L.³⁴ Furthermore, phenolic compounds with flavonoid structures have been shown to regulate diabetes by improving glucose and lipid levels.⁴³ Notably, compounds such as quercetin, epicatechin, kaempferol, and naringenin effectively inhibit the α-glucosidase enzyme, a crucial target in antidiabetic treatments.^45-47 Research by Jiménez et al (2016)⁴⁸ confirmed that high-polarity extracts of Hamelia patens were more effective inhibitors compared to low-polarity extracts. The pathogenesis of diabetes mellitus often results in the production of ROS, leading to glucose oxidation, increased lipid peroxidation, and heightened insulin resistance. The antioxidant activity of phenolic compounds may therefore play a role in managing and preventing the pathogenesis of diabetes mellitus.⁴⁹

Our study highlighted the presence of N,N-dimethyloctanamide in MO leaves, a compound with potential α-glucosidase inhibitory properties. Such inhibitors are essential for managing postprandial hyperglycemia in Type 2 Diabetes Mellitus (T2DM) by delaying carbohydrate breakdown and glucose absorption. The interaction of N,N-Dimethyloctanamide with the enzyme's active site could decrease its activity, slowing the conversion of disaccharides into glucose. Additionally, our study identified significant constituents in MO, including α-Linolenic acid, Stearic acid, 3-octenoic acid, and Tetradecanoic acid. Previous studies have noted that Tetradecanoic acid can inhibit α-glucosidase by up to 78%.⁵⁰^,51 Both Palmitic and Tetradecanoic acids have been recognized as significant fatty acids contributing to α-glucosidase inhibition.^50,51

While this study on the leaves of MO provides valuable insights into its strong antioxidant and α-glucosidase inhibitory properties, it has certain limitations. Firstly, there is a need for future molecular docking studies to elucidate the exact mechanisms of α-glucosidase inhibition by the fatty acids present in the extracts. These studies could help clarify interactions involving hydrogen bonding, hydrophobic interactions, or salt bridging. Furthermore, although mechanistic insights into these compounds are currently limited, similar derivatives have shown promise in enhancing glycemic control and mitigating diabetic complications through improved metabolic regulation.^51,52,53 This study is among the first to conduct a comprehensive GC-MS assessment of the EtOH and EtAc extracts of MO, which sheds light on their potential health benefits. Despite these limitations, the findings contribute valuable insights into the therapeutic applications of MO, particularly regarding its antioxidant properties and α-glucosidase inhibition. Further research is essential to explore these mechanisms and validate the therapeutic potential of MO in clinical settings.

Conclusion

The leaves of Moringa oleifera are a potent natural treatment that has strong antioxidant and α-glucosidase inhibitory properties. According to the study, ethanol and ethyl acetate extracts have unique chemical profiles with high levels of palmitic acid and α-linolenic acid, which support their potential as medicines. With a total phenolic concentration of 157.14 ± 14.46 mg GAE/g, MO's remarkable antioxidant ability is highlighted. Robust DPPH and ABTS tests confirmed this capability, demonstrating efficient free radical neutralization. For instance, the EtOH extract showed excellent α-glucosidase inhibition (IC50 = 15.01 µg/mL), confirming its long-standing use in diabetes treatment by postponing the absorption of carbohydrates and lowering postprandial hyperglycemia. With its abundance of phenolic compounds and beneficial fatty acids, MO is a great option for natural diabetes preventive and treatment methods. MO is a useful addition to the toolkit of natural therapeutic substances because of its many health benefits as it could be a highly effective natural antioxidant source, contributing to health promotion and disease prevention. Its diverse bioactive compounds offer promising applications in nutrition, medicine, and industry, which demand more research. The effectiveness of MO in clinical settings and its potential for incorporation into dietary supplements should be investigated in future research.

Footnotes

Acknowledgements

For their unwavering support during the research investigation, the researchers would like to thank the Deanship of Scientific Research at their linked universities.

ORCID iD

Ghassab M Al-Mazaideh

Author Contributions

Conceptualization, writing the original draft, reviewing and editing: L.H., A.A., I.A., R.A., F.A., H.A., G.M., M.H. Formal analysis, investigations, funding acquisition, reviewing, and editing: M.S., M.M., G.M., A.A., H.M. Resources, data validation, data curation, and supervision: L.H., A.A., G.M., F.A.

Funding

The authors received no financial support for the research, authorship, and/or publication of this article.

Declaration of Conflicting Interests

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Data Availability Statement

This article contains all of the data created or examined during this investigation.

Statement of Informed Consent

This article does not use human subjects, and informed consent is not relevant.

References

George

Obilana

Oyenihi

, et al. Moringa oleifera through the years: a bibliometric analysis of scientific research (2000-2020). South Afri J Botany. 2021;141:12-24. DOI: https://doi.org/10.1016/j.sajb.2021.04.025

Faris Shalayel

Al-Mazaideh

Almutairi

Alsubhi

Althaiban

. The computational interaction analyses of some vitamin D-related compounds with sterol 14-demethylase (CYP51) – could it be a glimmer of hope to find new anti-mucormycotic drugs extracted from plants-derived sterols? Nat Prod Commun. 2024;19(1):1-19. doi:https://doi.org/10.1177/1934578X231222106

Ahmad

Zhang

, et al. Evaluation of phytochemical and medicinal properties of Moringa (Moringa oleifera) as a potential functional food. South Afr J Botany. 2020;129:40-46. doi:https://doi.org/10.1016/j.sajb.2018.12.002d

Shalayel

MHF

Elbadri

Nourein

Ayed

Huneif

. Identification of novel targets of new insulin sensitizers- studies of related mechanism with other glucose-lowering agents. WJPR. 2025;4(6):228-247.

Fahey

. Moringa Oleifera: A Review of the Medicinal Potential. International Society for Horticultural Science (ISHS); 2017:209-224.

Anwar

Latif

Ashraf

, et al. Moringa oleifera: a food plant with multiple medicinal uses. Phytother Res. 2007;21:17-25. DOI: https://doi.org/10.1002/ptr.2023

Thurber

Fahey

. Adoption of Moringa oleifera to combat under-nutrition viewed through the lens of the “Diffusion of innovations” theory. Ecol Food Nutr. 2009;48:212-225. DOI: https://doi.org/10.1080/03670240902794598

Trigo

Castelló

Ortolá

, et al. Moringa oleifera: an unknown crop in developed countries with great potential for industry and adapted to climate change. Foods. 2020;10(1):31. DOI: https://doi.org/10.3390/foods10010031

Khattabi Rifi

Souabi

El Fels

, et al. Moringa oleifera organic coagulant to eliminate pollution in olive oil mill wastewater. Envir Nanotech, Monit & Manag. 2023;20:100871. DOI: https://doi.org/10.1016/j.enmm.2023.100871

10.

Makonnen

Hunde

Damecha

. Hypoglycaemic effect of aqueous extract in rabbits. Phytotherapy Res. 1997;11:147-148. DOI: https://doi.org/10.1002/(SICI)1099-1573(199703)11:2<147: AID-PTR41>3.0.CO;2-V

11.

Kar

Choudhary

Bandyopadhyay

. Comparative evaluation of hypoglycaemic activity of some Indian medicinal plants in alloxan diabetic rats. J Ethnopharmacol. 2003;84:105-108. DOI: https://doi.org/10.1016/s0378-8741(02)00144-7

12.

Ndong

Uehara

Katsumata

, et al. Effects of oral administration of moringa oleifera lam on glucose tolerance in goto-kakizaki and wistar rats. J Clin Biochem Nutr. 2007;40:229-233. DOI: https://doi.org/10.3164/jcbn.40.229

13.

Taweerutchana

Lumlerdkij

Vannasaeng

, et al. Effect of moringa oleifera leaf capsules on glycemic control in therapy-naïve type 2 diabetes patients: a randomized placebo controlled study. Evid Based Complement Alternat Med. 2017;2017:6581390. DOI: https://doi.org/10.1155/2017/6581390

14.

Olaoye

Owoeye

Nwobegu

. Facile green synthesis of plant-mediated selenium nanoparticles (SeNPs) using moringa oleifera leaf and bark extract for targeting α-amylase and α-glucosidase enzymes in diabetes management. Hybrid Advances. 2024;7:100281. DOI: https://doi.org/10.1016/j.hybadv.2024.100281

15.

Eid

WAM

Azab

DE-SH

Negm

. Characterization of a novel date energy bar fortified with Moringa oleifera leaves powder. J Future Foods. 2025;5:266-275. DOI: https://doi.org/10.1016/j.jfutfo.2024.07.006

16.

Gharsallah

Rezig

Rajoka

MSR

, et al. Moringa oleifera: processing, phytochemical composition, and industrial applications. South Afri J Botany. 2023;160:180-193. DOI: https://doi.org/10.1016/j.sajb.2023.07.008

17.

Kumaran

Joel Karunakaran

. In vitro antioxidant activities of methanol extracts of five Phyllanthus species from India. LWT – Food Science and Technology. 2007;40:344-352. DOI: https://doi.org/10.1016/j.lwt.2005.09.011

18.

Khalid

Al-Rimawi

Fawadleh

, et al. Evaluating the antioxidant, antimicrobial, and anticancer effects of Eminium spiculatum plant extracts. Nat Prod Commun. 2024;19(11):1-8. DOI: https://doi.org/10.1177/1934578x241299230

19.

Al-Rimawi

Khalid

Salah

, et al. Anticancer, antioxidant, and antibacterial activity of chemically fingerprinted extract from Cyclamen persicum Mill. Sci Rep. 2024;14:8488. DOI: https://doi.org/10.1038/s41598-024-65528-w

20.

Khalid

Al-Rimawi

Darwish

, et al. Assessment of the anticancer, antimicrobial, and antioxidant activities of the peganum harmala L. plant. Nat Prod Commun. 2024;19(6):1-10. DOI: https://doi.org/10.1177/1934578x241260597

21.

Al-Rimawi

Akkawi

Tarayrah

, et al. In vitro analysis of antimalarial activity of Achillea fragrantissima (Forssk.) sch.bip extracts based on Beta-hematin formation. Nat Prod Commun. 2024;19(4):1-9. DOI: https://doi.org/10.1177/1934578x241236015

22.

Velioglu

Mazza

Gao

, et al. Antioxidant activity and total phenolics in selected fruits, vegetables, and grain products. J Agr Food Chem. 1998;46:4113-4117. DOI: https://doi.org/10.1021/jf9801973

23.

Al-Mustafa

Al-Thunibat

. Antioxidant activity of some Jordanian medicinal plants used traditionally for treatment of diabetes. Pak J Biol Sci. 2008;11:351-358. DOI: https://doi.org/10.3923/pjbs.2008.351.358

24.

Benzie

IFF

Choi

S-W

. Chapter one – antioxidants in food: content, measurement, significance, action, cautions, caveats, and research needs. In: Henry

, ed. Advances in Food and Nutrition Research. Academic Press; 2014:1-53.

25.

Pellegrini

Proteggente

, et al. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radical Biol Med. 1999;26(9-10):1231-1237.

26.

Indrianingsih

Tachibana

Itoh

. In vitro evaluation of antioxidant and α-glucosidase inhibitory assay of several tropical and subtropical plants. Proced Env Sci. 2015;28:639-648. DOI: https://doi.org/10.1016/j.proenv.2015.07.075

27.

Dirir

Daou

Yousef

, et al. A review of alpha-glucosidase inhibitors from plants as potential candidates for the treatment of type-2 diabetes. Phytochem Rev. 2022;21:1049-1079. DOI: https://doi.org/10.1007/s11101-021-09773-1

28.

Dehshahri

Wink

Afsharypuor

Asghari

Mohagheghzadeh

. Antioxidant activity of methanolic leaf extract of moringa peregrina (Forssk.) Fiori. Res Pharm Sci. 2012;7(2):111-118.

29.

Katsoulieris

Mabley

Samai

, et al. alpha-Linolenic acid protects renal cells against palmitic acid lipotoxicity via inhibition of endoplasmic reticulum stress. Eur J Pharmacol. 2009;623:107-112. DOI: https://doi.org/10.1016/j.ejphar.2009.09.015

30.

Martinez

Tanabe

Cras-Méneur

, et al. Inhibition of Foxo1 protects pancreatic islet beta-cells against fatty acid and endoplasmic reticulum stress-induced apoptosis. Diabetes. 2008;57:846-859. DOI: https://doi.org/10.2337/db07-0595

31.

Fuentes

López-Miranda

Pérez-Martínez

, et al. Chronic effects of a high-fat diet enriched with virgin olive oil and a low-fat diet enriched with alpha-linolenic acid on postprandial endothelial function in healthy men. Br J Nutr. 2008;100:159-165. DOI: https://doi.org/10.1017/s0007114508888708

32.

Fiaccavento

Carotenuto

Minieri

, et al. Alpha-linolenic acid-enriched diet prevents myocardial damage and expands longevity in cardiomyopathic hamsters. Am J Pathol. 2006;169:1913-1924. DOI: https://doi.org/10.2353/ajpath.2006.051320

33.

Garman

Mulroney

Manigrasso

, et al. Omega-3 fatty acid rich diet prevents diabetic renal disease. Am J Physiol Renal Physiol. 2009;296(2):F306-F316. DOI: https://doi.org/10.1152/ajprenal.90326.2008

34.

Kumar

Prakash

. Enzymes inhibition and antidiabetic effect of isolated constituents from Dillenia indica. Biomed Res Int. 2013;2013:382063. DOI: https://doi.org/10.1155/2013/382063

35.

Das

Dharan

Pavitra

, et al. Investigation on the phenolic content in Moringa oleifera and its antimicrobial activity. Ind J Agr Res. 2022;56(3):255-261. doi: https://doi.org/10.18805/IJARe.A-5636

36.

Alhakmani

Kumar

Khan

. Estimation of total phenolic content, in-vitro antioxidant and anti-inflammatory activity of flowers of Moringa oleifera. Asian Pac J Trop Biomed. 2013;3(8):623-627. doi: https://doi.org/10.1016/S2221-1691(13)60126-4

37.

Amorós

Pretel

Almansa

, et al. Antioxidant and nutritional properties of date fruit from elche grove as affected by maturation and phenotypic variability of date palm. Food Sci Techno Inter. 2009;15:65-72. DOI: https://doi.org/10.1177/1082013208102758

38.

Shaheen

Ashfaq

Shamim

, et al. Antioxidant, antimicrobial, phytochemical and FTIR analysis of peganum harmala (fruit) ethanolic extract from cholistan desert, Pakistan. Dose Resp. 2022;20(3):15593258221126832. DOI: https://doi.org/10.1177/15593258221126832

39.

Asmat

Abad

Ismail

. Diabetes mellitus and oxidative stress-A concise review. Saudi Pharm J. 2016;24:547-553. DOI: https://doi.org/10.1016/j.jsps.2015.03.013

40.

Fayez

Zengin

Al-Rashood

, et al. The antioxidant and enzyme inhibitory potential of n-hexane-extracted oils obtained from three Egyptian cultivars of the golden dewdrop Duranta erecta Linn. Supported by their GC-MS metabolome analysis and docking studies. Antioxidants (Basel). 2022;11(10):1937. DOI: https://doi.org/10.3390/antiox11101937

41.

Sreelatha

Padma

. Antioxidant activity and total phenolic content of Moringa oleifera leaves in two stages of maturity. Plant Foods Hum Nutr. 2009;64:303-311. DOI: https://doi.org/10.1007/s11130-009-0141-0

42.

Pari

Kumar

. Hepatoprotective activity of moringa oleifera on antitubercular drug-induced liver damage in rats. JMed Food. 2002;5:171-177. DOI: https://doi.org/10.1089/10966200260398206

43.

Segwatibe

Cosa

Bassey

. Antioxidant and antimicrobial evaluations of moringa oleifera lam leaves extract and isolated compounds. Molecules. 2023;28(2):899. DOI: https://doi.org/10.3390/molecules28020899

44.

Fahey

. Moringa oleifera: a review of the medical evidence for its nutritional, therapeutic, and prophylactic properties: part 1. Trees for Life J. 2005;1:1-15. DOI: http://www.tfljournal.org/article.php/20051201124931586

45.

Vinayagam

. Antidiabetic properties of dietary flavonoids: a cellular mechanism review. Nutr Metab (Lond). 2015;12:60. DOI: https://doi.org/10.1186/s12986-015-0057-7

46.

Marella

. Flavonoids-The most potent poly-phenols as antidiabetic agents: an overview. Mod Appro Drug Des. 2017;1(3):1-5. DOI: DOI: https://doi.org/10.31031/MADD.2017.01.000513

47.

Vessal

Hemmati

Vasei

. Antidiabetic effects of quercetin in streptozocin-induced diabetic rats. Comparative Biochemistry and Physiology Part C: Toxicol Pharma. 2003;135:357-364. DOI: https://doi.org/10.1016/S1532-0456(03)00140-6

48.

Jiménez-Suárez

Nieto-Camacho

Jiménez-Estrada

, et al. Anti-inflammatory, free radical scavenging and alpha-glucosidase inhibitory activities of hamelia patens and its chemical constituents. Pharm Biol. 2016;54:1822-1830. DOI: https://doi.org/10.3109/13880209.2015.1129544

49.

Deka

Choudhury

Dey

. An overview on plant derived phenolic compounds and their role in treatment and management of diabetes. J Pharmacop. 2022;25:199-208. DOI: https://doi.org/10.3831/kpi.2022.25.3.199

50.

Lakshmanasenthil

Vinoth Kumar

Geetharamani

Shanthi Priya

. α-Amylase and α-glucosidase InhibitoryActivity of tetradecanoic acid (TDA) from Sargassum wightii with relevance to type 2 diabetes Mellitus. J Biol Act Prod Nature. 2018;8(3):180-191. https://doi.org/10.1080/22311866.2018.1474803

51.

Liu

Zhou

Zhang

Koyama

. Effect of a steaming treatment on the alpha-glucosidase inhibitory components in the brown alga Sargassum fusiform. Molecules. 2024;29(24):6000. doi: https://doi.org/10.3390/molecules29246000

52.

Ndarawit

Ochieng

Angwenyi

, et al. Discovery of α-amylase and α-glucosidase dual inhibitors from NPASS database for management of type 2 diabetes Mellitus: a chemoinformatic approach. PLoS One. 2024;19(11):e0313758. DOI: https://doi.org/10.1371/journal.pone.0313758

53.

Moelands

Lucassen

Akkermans

, et al. Alpha-glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database Syst Rev. 2018;12(12):Cd005061. DOI: https://doi.org/10.1002/14651858.CD005061.pub3

The Remarkable Benefits of Moringa oleifera : Antioxidant Strength and α - Glucosidase Inhibition

Abstract

Introduction

Methods

Results

Conclusion

Keywords

Introduction

Materials and Methods

Plant-based Material Collection Along with Extraction

GC-MS Analysis

The Measurement of Total Phenols

Assessment of Antioxidant Activities

DPPH Assay

ABTS Assay

Measurement of α-glucosidase Inhibition Effectiveness

Statistical Analysis

Results

GC-MS Detection of Phytochemicals

Total Phenolic Amount

Evaluation of Antioxidant Activity

Assessment of α-Glucosidase Inhibitory Activity

Discussion

Conclusion

Footnotes

Acknowledgements

ORCID iD

Author Contributions

Funding

Declaration of Conflicting Interests

Data Availability Statement

Statement of Informed Consent

References